Results 211 to 220 of about 4,702,470 (276)
Mitochondrial heterogeneity drives the evolution of fungicide resistance in <i>Phytophthora sojae</i>, with associated fitness trade-offs. [PDF]
Sci AdvYuan K +11 more
europepmc +1 more source
The Evolution of Command and Control Systems
, 1986 Baruch Fischhoff, Stephen Johnson
openalex +1 more source
Molecular Oncology, EarlyView.A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
A novel hybridization of birds of prey-based optimization with differential evolution mutation and crossover for chaotic dynamics identification. [PDF]
Sci RepEkinci S +4 more
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Early transitions in the evolution of cognition. [PDF]
Hist Philos Life SciNejad Kourki A.
europepmc +1 more source
Emergent Evolution of Behavior Arbitration System Based on the Immune System
, 1998 Yasuhiro Shirai +3 more
openalex +2 more sources
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source